Molecular Therapy
Volume 30, Issue 11, 2 November 2022, Pages 3394-3413
Original ArticleBET inhibition triggers antitumor immunity by enhancing MHC class I expression in head and neck squamous cell carcinoma
Under a Creative Commons license
open archive
Graphical abstract
Keywords
antitumor immunity
BET inhibition
head and neck squamous cell carcinoma
MHC class I molecules
PD-1
Cited by (0)
- 12
These authors contributed equally
© 2022 The American Society of Gene and Cell Therapy.